Thrombocytopenia in patients with chronic hepatitis C virus (HCV) infection is a major
problem. The pathophysiology is multifactorial, with auto-immunogenicity, direct bone …

Chronic infection with hepatitis C virus (HCV) is a major and growing public health concern
worldwide, including in Latin America. With more efficacious therapies becoming available …

Summary Background Interleukin (IL) 28 B single nucleotide polymorphisms can predict
sustained virological response (SVR) in hepatitis C virus (HCV) patients following pegylated …

Aim To analyze the genetic heterogeneity of the Amerindian and admixed population
(Mestizos) based on the IL28B (rs12979860, rs8099917) and IFNL4 (rs368234815) …

Direct-acting antiviral treatment for hepatitis C virus (HCV) infection is costly and does not
protect from re-infection. For human and chimpanzees, recovery from acute HCV infection …

Background and Aims Genetic polymorphisms near interleukin 28B gene are associated
with spontaneous and treatment induced clearance of hepatitis C virus (HCV). Our objective …

The hepatitis C virus (HCV) genotype is an important predictive outcome parameter for
pegylated interferon plus ribavirin therapy. Most published therapeutic trials to date have …

Hepatitis C is a common cause of end-stage liver disease, and the main indication for liver
transplantation in Latin America. Treatment of hepatitis C infected patients improves …

С марта 2020 года по настоящее время было зарегистрировано значительное
увеличение обращаемости коллег-медиков, работающих в COVID-отделениях, с …

Genetic polymorphisms adjacent to IL28B have been previously associated with
spontaneous clearance of hepatitis C virus (HCV) and a higher rate of sustained virological …